Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Apricus Biosciences Inc announces national phase approval for Vitaros in Spain


Thursday, 24 Apr 2014 08:00am EDT 

Apricus Biosciences Inc:Spanish Agency for Medicines and Health Products has granted national phase approval to Vitaros, Apricus' novel topical on-demand treatment for erectile dysfunction.With approval in Spain, Company has now received total of ten national phase approvals for Vitaros. 

Company Quote

1.92
-0.03 -1.54%
4:00pm EDT